P.A.W. Capital Corp Gsk PLC Transaction History

P.A.W. Capital Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	BUY	$34.27 - $40.01 $34,270 - $40,010	1,000 Added 5.26%	20,000 $714,000
Q4 2020 Feb 11, 2021	BUY	$34.07 - $39.94 $102,210 - $119,820	3,000 Added 18.75%	19,000 $699,000
Q3 2020 Nov 09, 2020	BUY	$38.11 - $42.99 $38,110 - $42,990	1,000 Added 6.67%	16,000 $602,000
Q4 2019 Jan 28, 2020	SELL	$42.0 - $48.25 $42,000 - $48,250	-1,000 Reduced 6.25%	15,000 $705,000
Q1 2018 Apr 26, 2018	SELL	$36.18 - $40.15 $144,720 - $160,600	-4,000 Reduced 20.0%	16,000 $625,000
Q4 2017 Jan 31, 2018	BUY	$35.34 - $41.9 $176,700 - $209,500	5,000 Added 33.33%	20,000 $709,000
Q3 2017 Oct 23, 2017	BUY	$39.44 - $41.55 $591,600 - $623,250	15,000	15,000 $609,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.